This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
3 Soaps & Cleaning Stocks That are Braving Industry Challenges
by Vidya Nair
Pandemic-led rise in input costs are a headwind for several soap and cleaning materials companies. Nonetheless, strong demand for personal care items is a boon for players like Procter & Gamble (PG), Unilever (UL) and Church & Dwight (CHD).
Moving Average Crossover Alert: Unilever
by Zacks Equity Research
Unilever (UL) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
New Strong Sell Stocks for February 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
ViacomCBS' (VIAC) BET to Cover Presidential Inauguration Live
by Zacks Equity Research
ViacomCBS (VIAC) owned BET news is set to broadcast live extended coverage of inauguration day events of the 46th President of the United States, Joe Biden.
5 Soaps & Cleaning Products Stocks Worth a Look Amid Coronavirus Woes
by Vidya Nair
The COVID-led rising demand for hygiene products is a boon for several soap and cleaning materials companies such as Procter & Gamble (PG), Unilever (UL), Colgate (CL), Clorox (CLX) and Church & Dwight (CHD), However, rising input costs are a concern.
PepsiCo's (PEP) Micro-Fulfillment Center to Enhance Delivery
by Zacks Equity Research
PepsiCo (PEP) has launched a micro-fulfillment center in Illinois to stay ahead in the ongoing online race stemming from the coronavirus-led stay-at-home trend.
Colgate (CL) Up on Q3 Earnings & Sales Beat, Gives Solid view
by Zacks Equity Research
Colgate (CL) reports accelerated earnings and sales growth in third-quarter 2020 on strong demand for its products, innovation and positive e-commerce trends.
Glaxo Receives EU Approval for Multiple Myeloma Drug Blenrep
by Zacks Equity Research
The European Commission lends a nod to Glaxo's (GSK) Blenrep as a monotherapy for patients with relapsed/refractory multiple myeloma, having received at least four previous therapies.
Glaxo's Multiple Myeloma Candidate Gets FDA Committee Nod
by Zacks Equity Research
Glaxo's (GSK) belantamab mafodotin gets FDA's Oncologic Drugs Advisory Committee votes as its benefits outweigh risks for relapsed/refractory multiple myeloma patients.
Diageo (DEO) Plans to Launch Paper Packaging for Spirits
by Zacks Equity Research
Diageo (DEO) to launch a paper bottle for the Johnnie Walker brand in 2021, replacing the existing glass bottles.
Facebook's Ad Controversy Continues
by Sejuti Banerjea
Zuckerberg is taking a tough stand on the obvious, he could have been more agreeable.
Stock Market News for Jun 29, 2020
by Zacks Equity Research
Benchmarks tumbled on Friday after several U.S. states rolled back some reopening measures due to the spike in new coronavirus cases, raising investors??? concern regarding economic recovery.
ETF Strategies to Play the Wall Street Rally
by Sweta Jaiswal, FRM
We discuss ETF strategies to gain from the current momentum in the U.S. financial markets.
Corporate News for Dec 18, 2019
by Zacks Equity Research
Companies In The News Are: TGE, WOR, UL, CLVS
3 Dow Stocks for Dividend Investors to Buy as Stock Market Keeps Climbing
by Benjamin Rains
Today we searched for highly-ranked, large-cap stocks using our Zacks Stock Screener that dividend investors might want to consider buying. All three of the stocks also happened to be Dow components from completely different industries...
The Zacks Analyst Blog Highlights: Lloyds Banking, Unilever, BP, RELX and Vodafone
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lloyds Banking, Unilever, BP, RELX and Vodafone
Soap & Cleaning Materials Stock Outlook Buoyant on Innovation
by Rajani Lohia
The FMCG space gains from continued investment in brands, innovation, cost-containment and pricing actions. Escalating operating costs and unfavorable currency rates are headwinds.
5 Stocks to Profit as U.K. Economy Hits Decade Low in Q3
by Zacks Equity Research
Brexit uncertainty hurts Britain's labor market, manufacturing sector and trade prospects, leading to slowest annual growth rate of the U.K. economy in nearly a decade.
Estee Lauder (EL) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Unilever PLC (UL) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Unilever PLC (UL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Church & Dwight Sales to Gain on International Unit & More
by Zacks Equity Research
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
Is Unilever PLC (UL) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UL or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Here's Why Colgate (CL) Deserves a Place in Your Portfolio
by Zacks Equity Research
Colgate (CL) exhibits strong surprise trend, owing to accelerated investments in brands, higher pricing and strong innovation along with expansion in new markets and channels.
Are Investors Undervaluing Unilever PLC (UL) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.